These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2855330)
1. Comparison between the cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) and clonidine in the conscious sino-aortic denervated rat. Petty MA; Kintz J; Di Francesco GF; Fozard JR J Auton Pharmacol; 1988 Dec; 8(4):267-76. PubMed ID: 2855330 [TBL] [Abstract][Full Text] [Related]
2. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat. Gradin K; Pettersson A; Hedner T; Persson B J Neural Transm; 1985; 62(3-4):305-19. PubMed ID: 3161997 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. Fozard JR; Mir AK; Middlemiss DN J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat. Dreteler GH; Wouters W; Saxena PR Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096 [TBL] [Abstract][Full Text] [Related]
5. Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats. Bouhelal R; Loubatières-Mariani MM; Mir AK Br J Pharmacol; 1990 May; 100(1):173-9. PubMed ID: 2142614 [TBL] [Abstract][Full Text] [Related]
6. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat. Chaouloff F; Jeanrenaud B J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757 [TBL] [Abstract][Full Text] [Related]
7. Evidence that the putative 5-HT1A receptor agonists, 8-OH-DPAT and ipsapirone, have a central hypotensive action that differs from that of clonidine in anaesthetised cats. Ramage AG; Fozard JR Eur J Pharmacol; 1987 Jun; 138(2):179-91. PubMed ID: 2957220 [TBL] [Abstract][Full Text] [Related]
8. Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in conscious rats. Bagdy G; Szemeredi K; Murphy DL J Pharm Pharmacol; 1989 Apr; 41(4):270-2. PubMed ID: 2568470 [TBL] [Abstract][Full Text] [Related]
9. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor. Tricklebank MD; Neill J; Kidd EJ; Fozard JR Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789 [TBL] [Abstract][Full Text] [Related]
11. Role of the adrenal gland in the metabolic and cardiovascular effects of 8-OH-DPAT in the rat. Bouhelal R; Mir AK Eur J Pharmacol; 1990 May; 181(1-2):89-95. PubMed ID: 2143731 [TBL] [Abstract][Full Text] [Related]
12. Influence of urapidil and 8-OH-DPAT on brain 5-HT turnover and blood pressure in rats. Valenta B; Kotai E; Weisz E; Singer EA J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S68-74. PubMed ID: 1702489 [TBL] [Abstract][Full Text] [Related]
13. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil. Doods HN; Boddeke HW; Kalkman HO; Hoyer D; Mathy MJ; van Zwieten PA J Cardiovasc Pharmacol; 1988 Apr; 11(4):432-7. PubMed ID: 2453746 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and adrenaline-releasing effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in streptozotocin diabetic rats. Chaouloff F; Blanc J; Baudrie V; Laude D; Elghozi JL Life Sci; 1991; 48(26):2543-52. PubMed ID: 1828521 [TBL] [Abstract][Full Text] [Related]
15. Differential cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, 5-methyl-urapidil and MDL 75,608A in conscious spontaneously hypertensive rats. Buisson-Defferier S; Hibert M; van den Buuse M Fundam Clin Pharmacol; 1993; 7(9):499-511. PubMed ID: 7906241 [TBL] [Abstract][Full Text] [Related]
16. Hypotensive action of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in spontaneously hypertensive rats. Martin GE; Lis EV Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):251-61. PubMed ID: 3159366 [TBL] [Abstract][Full Text] [Related]
17. Effect of chronic treatment on the cardiovascular and behavioral responses of 8-OH-DPAT in conscious normotensive rats. Kolbasa KP; McCall RB; Ludens JH Eur J Pharmacol; 1991 Feb; 193(3):275-81. PubMed ID: 1829040 [TBL] [Abstract][Full Text] [Related]
18. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin. Marsden CA; Martin KF Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656 [TBL] [Abstract][Full Text] [Related]
19. Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat. Chaouloff F; Baudrie V; Laude D Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):381-4. PubMed ID: 1970616 [TBL] [Abstract][Full Text] [Related]
20. Systemic and regional haemodynamic responses to microinjection of 5-HT agonists in the rostral ventrolateral medulla in the rat. Lovick TA Neurosci Lett; 1989 Dec; 107(1-3):157-61. PubMed ID: 2533333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]